(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally...
Stats | |
---|---|
Dagens volum | 558 779 |
Gjennomsnittsvolum | 2.52M |
Markedsverdi | 242.38M |
EPS | $0 ( 2024-03-04 ) |
Neste inntjeningsdato | ( $-0.200 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.910 |
ATR14 | $0.00300 (0.23%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-05 | Deep Track Capital, Lp | Buy | 0 | Common Stock |
2024-02-20 | Zalevsky Jonathan | Sell | 9 014 | Common Stock |
2024-02-20 | Wilson Mark Andrew | Sell | 7 606 | Common Stock |
2024-02-20 | Robin Howard W | Sell | 20 033 | Common Stock |
2023-12-13 | Zalevsky Jonathan | Buy | 250 000 | Stock Option |
INSIDER POWER |
---|
84.96 |
Last 97 transactions |
Buy: 6 976 063 | Sell: 637 451 |
Volum Korrelasjon
Nektar Therapeutics Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Nektar Therapeutics Korrelasjon - Valuta/Råvare
Nektar Therapeutics Økonomi
Annual | 2023 |
Omsetning: | $90.12M |
Bruttogevinst: | $53.48M (59.34 %) |
EPS: | $-1.450 |
FY | 2023 |
Omsetning: | $90.12M |
Bruttogevinst: | $53.48M (59.34 %) |
EPS: | $-1.450 |
FY | 2022 |
Omsetning: | $92.06M |
Bruttogevinst: | $70.42M (76.50 %) |
EPS: | $-1.970 |
FY | 2021 |
Omsetning: | $101.91M |
Bruttogevinst: | $77.01M (75.57 %) |
EPS: | $-2.86 |
Financial Reports:
No articles found.
Nektar Therapeutics
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and adjuvant melanoma; phase 2 clinical trial for the treatment of renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; phase 1/2A clinical trial to treat squamous cell carcinoma of the head and neck; phase 1/2 clinical trial for the treatment of solid tumors; and phase 1B clinical trial to treat COVID-19. It is also developing NKTR-358, a cytokine Treg stimulant that is in phase 2 clinical trial for the treatment of systemic lupus erythematosus and ulcerative colitis, as well as phase 1B clinical trial to treat atopic dermatitis and psoriasis; NKTR-255, an IL-15 receptor agonist, which is in phase 1/2 clinical trial for the treatment of non-Hodgkin's lymphoma and multiple myeloma, and head and neck cancer and colorectal cancer; and NKTR-262, a toll-like receptor agonist that is in phase 1/2 clinical trial to treat solid tumors, as well as various other drug candidates. The company has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma S.A.; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; Amgen Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; Baxalta Incorporated; Eli Lilly and Company; Merck KGaA; and SFJ Pharmaceuticals, Inc. Nektar Therapeutics was incorporated in 1990 and is headquartered in San Francisco, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.